MétaCan
Menu
Back to cohort
Record W3159277719

Role of NADPH:cytochrome P450 reductase in RH1 activation

2005· article· en· W3159277719 on OpenAlexaffabout
Marsha K. Leith, Tyler Digby, Brian B. Hasinoff, Asher Begleiter

Bibliographic record

Venuenot available
Typearticle
Languageen
FieldPharmacology, Toxicology and Pharmaceutics
TopicBioactive Compounds and Antitumor Agents
Canadian institutionsUniversity of ManitobaCancerCare Manitoba
Fundersnot available
KeywordsDicoumarolReductaseEnzymeBiochemistryCytotoxicityCytochrome P450 reductaseTransfectionCytochrome P450BiologyIn vitroCytochrome cNAD+ kinaseApoptosisGene
DOInot available

Abstract

fetched live from OpenAlex

5851 RH1 is a novel diaziridinylbenzoquinone bioreductive agent that has recently entered phase 1 clinical trials. It is an excellent substrate for the obligate two electron-reducing enzyme NQO1 (DT-diaphorase), and studies have demonstrated a relationship between NQO1 expression levels and drug response. It has been proposed that RH1 may be an effective NQO1-directed antitumor agent for the therapy of cells with elevated NQO1 activity. However, bioreductive agents may also be substrates for other reducing enzymes such as the 1-electron reducing enzyme, NADPH-cytochrome P450 reductase (P450 reductase), and therefore the role of this reducing enzyme in activating RH1 was examined. RH1 reduction by purified P450 reductase yielded a very strong electron paramagnetic resonance (EPR) signal, suggesting that RH1 could be reduced by this enzyme. Spectroscopic studies monitoring the disappearance of NADPH when RH1 was incubated with purified P450 reductase or NQO1 confirmed that this agent can be a substrate for either enzyme, and that under aerobic conditions RH1 undergoes redox cycling. To examine whether P450 reductase can play a role in activating RH1 in tumor cells, we used T47D human breast cancer cells and T47D cells transfected with the P450 reductase gene which have 20-fold increased P450 reductase activity. Pretreatment of the transfected T47D cells with the P450 reductase inhibitor, diphenyliodonium chloride (DPIC), did not inhibit RH1 cytotoxicity. In contrast, pretreatment of the transfected T47D cells with the NQO1 inhibitor, dicoumarol, significantly inhibited the of cytotoxicity of RH1, confirming the role of NQO1 as an activator of this agent. However, if the transfected cells were pretreated with both inhibitors there was additional inhibition of cytotoxicity compared with dicoumarol alone, suggesting that in the absence of NQO1 activity, high levels of P450 reductase activity could contribute to RH1 activation and cytotoxicity. A similar study in the parental T47D cells showed that pretreatment with both enzyme inhibitors did not result in greater inhibition of cytotoxicity than pretreatment with dicoumarol alone. These results suggest that although P450 reductase can reduce RH1, NQO1 is the major activator of this agent. and P450 reductase likely does not play a role in RH1 activation at normal cellular levels of this enzyme. (Supported by the National Cancer Institute of Canada with funds from the Canadian Cancer Society and the CancerCare Manitoba Foundation)

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesInsufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.115
Threshold uncertainty score0.998

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.096
GPT teacher head0.432
Teacher spread0.336 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2005
Admission routes2
Has abstractyes

Explore more

Same topicBioactive Compounds and Antitumor AgentsFrench-language works237,207